Xarelto® (Rivaroxaban) for Treatment of Acute Venous Thromboembolism (VTE) and VTE Secondary Prevention

An oral factor Xa direct inhibitor for the treatment of acute venous thromboembolism (VTE) and prevention of VTE recurrence.

If you have a Hayes login, click here to view the full report on the Knowledge Center.